Opti Capital Management, LP - Q2 2022 holdings

$1.04 Billion is the total value of Opti Capital Management, LP's 43 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 100.0% .

 Value Shares↓ Weighting
ExitNEOGENOMICS INCnote 0.250% 1/1$0-1,500,000
-100.0%
-0.08%
ExitCOUPA SOFTWARE INCnote 0.375% 6/1$0-3,500,000
-100.0%
-0.24%
ExitVIAVI SOLUTIONS INCnote 1.000% 3/0$0-3,096,000
-100.0%
-0.32%
ExitOMEROS CORPnote 6.250%11/1$0-6,100,000
-100.0%
-0.46%
ExitPTC THERAPEUTICS INCnote 3.000% 8/1$0-8,000,000
-100.0%
-0.66%
ExitKARYOPHARM THERAPEUTICS INCnote 3.000%10/1$0-11,460,000
-100.0%
-0.77%
ExitNEOGENOMICS INCnote 1.250% 5/0$0-15,750,000
-100.0%
-1.09%
ExitAVAYA HLDGS CORPnote 2.250% 6/1$0-25,792,000
-100.0%
-2.04%
ExitMANDIANT INCnote 1.625% 6/0$0-36,309,000
-100.0%
-2.92%
ExitSAILPOINT TECHNOLOGIES HLDGSnote 0.125% 9/1$0-32,030,000
-100.0%
-4.79%
ExitCONMED CORPnote 2.625% 2/0$0-50,065,000
-100.0%
-6.97%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-08-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
SUPERNUS PHARMACEUTICALS INC14Q1 20236.9%
NEW RELIC INC14Q1 20237.6%
8X8 INC NEW13Q3 20237.4%
MANDIANT INC12Q1 20229.9%
NUTANIX INC12Q4 20227.3%
OPKO HEALTH INC12Q3 20232.1%
INSIGHT ENTERPRISES INC10Q3 20235.6%
ALTERYX INC10Q3 20234.6%
IONIS PHARMACEUTICALS INC10Q1 20233.6%
MODEL N INC10Q3 20231.7%

View Opti Capital Management, LP's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-05-15
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14

View Opti Capital Management, LP's complete filings history.

Compare quarters

Export Opti Capital Management, LP's holdings